The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...
The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
Obstructive sleep apnea occurs when a person’s upper airway becomes blocked ... The FDA first approved Zepbound to treat ...
Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with ...
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Medpage Today on MSN5d
FDA Approves First Sleep Apnea Drug"Today's approval marks the first drug treatment option for certain patients with obstructive sleep apnea," said Sally ...
Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...
The approval was based on the results of the SURMOUNT-OSA trial, which found patients had fewer breathing disruptions.
Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback